Adenosine Injection
Product Images NDC 25021-301

2 FDA label images from Sagent Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Adenosine (NDC 25021-301). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Ade0b 0000 01)

Structural Formula (Ade0b 0000 01)
Chemical structure of adenosine, showing its purine base fused to a ribose sugar with attached hydroxyl groups and amine group on the base ring.*
FDA Label Image

Package Label – Principal Display Panel – Syringe Label (Ade0b 0000 02)

Package Label – Principal Display Panel – Syringe Label (Ade0b 0000 02)
Label for Adenosine Injection, USP 3 mg/mL in a 2 mL syringe providing a total of 6 mg per syringe. The product is for rapid bolus intravenous use and is manufactured for Sagent Pharmaceuticals. The label includes a dosage scale from 1.5 mg to 6 mg and features the Sagent logo and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.